Abstract:To study the clinical correlation between fasting plasma glucose, lipid metabolism, prostate-specific antigen and prostate volume in patients with benign prostatic hyperplasia, and to explore the combined effect as diagnostic indicators. A total of 108 patients with benign prostatic hyperplasia treated in Beijing University of Chinese Medicine Third Affiliated Hospital from June 2021 to March 2023 were retrospectively analyzed as the hyperplasia group, and 98 healthy physical examination personnel were selected as the control group during the same period. Compare the differences in levels of fasting plasma glucose (FPG), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), small and dense low-density lipoprotein cholesterol (sdLDL-C), homocysteine, lipoprotein a (LPa), prostate specific antigen (PSA), and free prostate specific antigen (fPSA) between two groups of patients. Using Pearson analysis method to analyze the correlation between the above indicators and the size of prostate volume in patients with benign prostatic hyperplasia; using multiple linear regression to analyze the influencing factors of prostate volume enlargement; draw receiver operating characteristic (ROC) curves and analyze the application value of individual and combined detection of HDL, FPG, PSA, and fPSA. The results showed that there were significant differences in HDL, FPG, PSA, and fPSA levels between the control group and the proliferative group(P<0.05). The size of prostate volume is negatively correlated with HDL(r=-0.183, P<0.05) and positively correlated with FPG (r=0.202, P<0.05), PSA(r=0.412, P<0.05), and fPSA(r=0.425, P<0.05). The results of multiple linear regression analysis showed that HDL(P=0.000), FPG(P=0.048), PSA(P=0.044), and fPSA (P=0.012) were risk factors for increased volume of benign prostatic hyperplasia; ROC curve analysis shows that the AUC of HDL, FPG, PSA, and fPSA combined detection is 0.823, which is better than individual detection. In conclusion,HDL, FPG, PSA, fPSA has close correlation with hyperplasia of prostate, the joint detection may has better prediction for benign prostatic hyperplasia.

Comparison of Clinical and Physiological Parameters for Benign Prostatic Hyperplasia in Hypertensive and Normotensive Patients.

Effect of Hypertension on Bacteria Composition of Prostate Biopsy in Patients with Benign Prostatic Hyperplasia and Prostate Cancer in PSA Grey-Zone.

Comparing Clinical Parameters of Abnormal and Normal Fasting Blood Glucose in Benign Prostatic Hyperplasia Patients.

Association Study Between Benign Prostatic Hyperplasia and Primary Hypertension

Relationship Between Lower Urinary Tract Symptoms and Objective Measures of Benign Prostatic Hyperplasia: a Chinese Survey

Clinical study the relationship between symptomatic parameters of benign prostate hyperplasia and sexual function

Correlation between primary hypertension and benign prostatic hyperplasia in the elderly

Association Study Between Primary Hypertension and Benign Prostatic Hyperplasia

[Study on the correlation between glycolipids and prostate volume in patients with benign prostatic hyperplasia]

Correlation of Prostatic Morphological Parameters and Clinical Progression in Aging Chinese Men with Benign Prostatic Hyperplasia: Results from a Cross-Sectional Study.

Correlation Between Metabolic Syndrome and Clinical Progression in Patients with Benign Prostatic Hyperplasia

Prostatic Anatomical Parameters Correlate with Clinical Characteristics Suggestive of Benign Prostatic Hyperplasia

The Correlation Between Metabolic Syndrome and Benign Prostatic Hyperplasia in Men over 50 Years O1d

Relationship Between Serum Sex Hormones Levels and Degree of Benign Prostate Hyperplasia in Chinese Aging Men

[Correlation Between Prostatic Parameters of Transrectal Ultrasonography and Age in Patients with Benign Prostatic Hyperplasia].

A Retrospective Study: Correlation of Histologic Inflammation in Biopsy Specimens of Chinese Men Undergoing Surgery for Benign Prostatic Hyperplasia with Serum Prostate-Specific Antigen.

Correlation between Benign Prostatic Hyperplasia and Metabolic Syndrome

Study on the relationship between age,prostate volume and prostate specific antigen of patients with benign prostatic hyperplasia

The Relationship Between the Clinical Progression of Benign Prostatic Hyperplasia and Metabolic Syndrome: A Prospective Study

Relationships between total/free prostate-specific antigen and prostate volume in Chinese men with biopsy-proven benign prostatic hyperplasia

The Association Between Metabolic Syndrome And Benign Prostatic Hyperplasia: A Systematic Review And Meta-Analysis